Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3290281
Max Phase: Preclinical
Molecular Formula: C21H35N3O3
Molecular Weight: 377.53
Molecule Type: Small molecule
Associated Items:
ID: ALA3290281
Max Phase: Preclinical
Molecular Formula: C21H35N3O3
Molecular Weight: 377.53
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCc1cnnn1C[C@H]1O[C@H](OCCC(C)C)C=CC1=O
Standard InChI: InChI=1S/C21H35N3O3/c1-4-5-6-7-8-9-10-18-15-22-23-24(18)16-20-19(25)11-12-21(27-20)26-14-13-17(2)3/h11-12,15,17,20-21H,4-10,13-14,16H2,1-3H3/t20-,21+/m1/s1
Standard InChI Key: YNRFWCFYAQGXNC-RTWAWAEBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 377.53 | Molecular Weight (Monoisotopic): 377.2678 | AlogP: 4.09 | #Rotatable Bonds: 13 |
Polar Surface Area: 66.24 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.07 | CX LogP: 5.65 | CX LogD: 5.65 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.48 | Np Likeness Score: 0.23 |
1. Sharma S, Saquib M, Verma S, Mishra NN, Shukla PK, Srivastava R, Prabhakar YS, Shaw AK.. (2014) Synthesis of 2,3,6-trideoxy sugar triazole hybrids as potential new broad spectrum antimicrobial agents., 83 [PMID:24992075] [10.1016/j.ejmech.2014.06.048] |
Source(1):